Prediction Markets Under Fire 16 States Take Legal Action One Enacts Ban Burberry Shares Jump on Speculation of Potential Moncler Acquisition Bid Healthcare Leads as SP 500 Edges Higher Tech Also Rallies Europe Faces AI Dependency Risk as Report Highlights Trade Imbalance with US and Asia Rising Private Credit Defaults Strain Banks and Insurers Amid Higher Rates AnheuserBusch InBev Shares Dip as Quarterly Sales Miss Market Expectations High Templar Tech Limited HTT Q1 2023 Earnings Positive EPS Result Drives Sharp Stock Rally TCBX Q1 2026 Earnings Earnings Per Share Surpasses Estimates Stock Edges Slightly Lower SHBI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported ICU Medical ICUI Q1 2026 Earnings Strong EPS Beat Lifts Shares as Medical Device Demand Holds SEVN Q1 2026 Earnings Slight EPS Beat Amidst Market Headwinds CapsoVision CV Holds Steady Near Key Support Amid Low Volatility Otter Tail Corporation OTTR Edges Lower Navigating Support Levels Amidst Mixed Signals Voya Financial VOYA Slips Slightly as Stock Holds Within Established Range ECB Bancorp Inc ECBK Experiences Modest Decline Amid LowVolume Trading NCS Multistage Holdings NCSM Eases Slightly as Traders Eye Key Support and Resistance Levels Alphabet Inc GOOG in Focus Evaluating Its Position Among Communication Stocks LiveWire Group Inc LVWR Q1 2026 Earnings Narrowing Loss Amid Strategic Transition Unum Group UNM Holds Steady Near 84 as Market Weighs Insurance Sector Sentiment CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher Rezolute Inc RZLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise IT Tech Packaging Q3 2025 Earnings Reports Net Loss Per Share of 011 Shares Dip SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue BLFY Q3 2025 Earnings EPS Falls Short of Estimates Amid Challenging Operating Environment Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges